Suppr超能文献

一种用于生物正交预靶向的新型抗体-四嗪缀合物的研发。

Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.

作者信息

Maggi Agnese, Ruivo Eduardo, Fissers Jens, Vangestel Christel, Chatterjee Sneha, Joossens Jurgen, Sobott Frank, Staelens Steven, Stroobants Sigrid, Van Der Veken Pieter, Wyffels Leonie, Augustyns Koen

机构信息

Laboratory of Medicinal Chemistry, University of Antwerp, Belgium.

出版信息

Org Biomol Chem. 2016 Aug 21;14(31):7544-51. doi: 10.1039/c6ob01411a. Epub 2016 Jul 19.

Abstract

Recently, bioorthogonal chemistry based on the Inverse Electron-Demand Diels-Alder (IEDDA) cycloaddition between 1,2,4,5-tetrazines and trans-cyclooctene (TCO) analogues added an interesting dimension to molecular imaging. Until now, antibodies (Abs) were tagged with TCO and after pretargeting they were reacted with tetrazines substituted with reporters. However, TCO tags have the tendency to degrade under physiological conditions, and due to their hydrophobic nature are buried within the protein. This results in loss of reactivity and a low Ab functional loading. To circumvent these problems, we report for the first time an approach in which tetrazines are used as tags for antibody (Ab) modification, and TCO as the imaging agent. We developed a new Ab-tetrazine conjugate, which displays a high functional loading, good stability and reactivity. We utilized this immunoconjugate for live-cell imaging together with novel TCO probes, resulting in selective and rapid labeling of SKOV-3 cells. Our approach may be useful for in vivo pretargeted imaging.

摘要

最近,基于1,2,4,5-四嗪与反式环辛烯(TCO)类似物之间的逆电子需求狄尔斯-阿尔德(IEDDA)环加成反应的生物正交化学为分子成像增添了有趣的维度。到目前为止,抗体(Abs)用TCO标记,预靶向之后与用报告基团取代的四嗪反应。然而,TCO标签在生理条件下有降解的倾向,并且由于其疏水性而埋藏在蛋白质内部。这导致反应性丧失和抗体功能负载量低。为了规避这些问题,我们首次报道了一种方法,其中四嗪用作抗体(Ab)修饰的标签,而TCO用作成像剂。我们开发了一种新的抗体-四嗪偶联物,其显示出高功能负载量、良好的稳定性和反应性。我们将这种免疫偶联物与新型TCO探针一起用于活细胞成像,从而实现了对SKOV-3细胞的选择性快速标记。我们的方法可能对体内预靶向成像有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验